Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Elective primary total hip arthroplasty in octogenarians.

L Daniel Wurtz1, Judy R Feinberg, William N Capello

  • 1Department of Orthopaedic Surgery, Indiana University School of Medicine, 541 Clinical Drive-CL600, Indianapolis, IN 46202, USA. dwurtz@iupui.edu

The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|May 6, 2003
PubMed
Summary

Elective total hip arthroplasty (THA) offers significant pain relief and improved mobility for patients aged 80 and older with hip arthritis. While complications can occur, the procedure demonstrates good safety and effectiveness in this age group.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From Birth to Practice: Characterizing the Geographic Migration of US Orthopaedic Surgeons.

The Journal of the American Academy of Orthopaedic Surgeons·2026
Same author

TRAF7-Mutated Fibromyxoid Spindle Cell Tumor of Bone: An Osseous Case Expanding the Spectrum of TRAF7-Mutated Tumors With Over 20 Years Clinical Follow-Up.

Genes, chromosomes & cancer·2026
Same author

Dual CDK4/6-PI3K/mTOR inhibition reinforces cytostatic programs and tumor control in preclinical models of primary and metastatic osteosarcoma.

Neoplasia (New York, N.Y.)·2026
Same author

Practice Patterns Vary Among Orthopedic, Plastic, and General Surgeons Resecting Soft Tissue Tumors of the Extremities and Pelvis.

Journal of surgical oncology·2025
Same author

Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for Osteosarcoma.

Cancer research communications·2025
Same author

Repurposing Romidepsin for Osteosarcoma: Screening FDA-Approved Oncology Drugs with Three-Dimensional Osteosarcoma Spheroids.

bioRxiv : the preprint server for biology·2025

Area of Science:

  • Orthopedic Surgery
  • Geriatric Medicine
  • Reconstructive Surgery

Background:

  • Total hip arthroplasty (THA) is a well-established treatment for end-stage hip arthritis.
  • Traditionally used for hip fractures in the elderly, THA is increasingly performed electively in octogenarians due to increased longevity and activity levels.
  • This study addresses the efficacy of elective THA in patients aged 80+ with severe hip arthritis.

Purpose of the Study:

  • To evaluate the safety and effectiveness of elective primary total hip arthroplasty (THA) in patients aged 80 years and older.
  • To assess clinical outcomes, including pain, ambulation, and functional improvement.
  • To document radiographic findings and complication rates in this elderly cohort.

Main Methods:

  • Retrospective review of 40 patients (46 THAs) aged 80+ undergoing elective primary THA.

Related Experiment Videos

  • Clinical assessments included pain levels, gait (limp), and need for assistive devices.
  • Radiographic evaluation focused on implant stability, heterotopic ossification, and osteolysis. Complications and reoperations were recorded.

    • Main Results:

    • At an average 4-year follow-up, 80% of patients were pain-free and 70% ambulated without assistance.
    • Radiographically, all implants remained stable with no evidence of osteolysis.
    • Medical complications occurred in 27.5% and hip-related complications in 15%, with no life-threatening events. Four patients required reoperation, primarily for dislocation.

    Conclusions:

    • Elective total hip arthroplasty is a safe and effective procedure for managing end-stage hip osteoarthritis in octogenarians.
    • While risks exist, particularly due to comorbidities, the benefits of pain reduction and functional improvement are substantial.
    • Low mortality rates support THA as a viable option for active elderly individuals with hip arthritis.